Sec. 2. Research program to improve diagnostic safety and quality
444 words·~2 min read·
/bill/118/s/5613/is/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Part B of title IX of the Public Health Service Act ( 42 U.S.C. 299b et seq. ) is amended by adding at the end the following: The Director shall establish a comprehensive program of research and quality improvement to— assess and understand diagnostic errors, including diagnostic delays, and how to eliminate common failures in the diagnostic process that lead to significant patient harm; and identify, develop, implement, and disseminate evidence-based strategies and best practices for improving diagnostic quality, safety, and health care value. The program established under subsection
(a)shall include the following: A portfolio of conducted and supported activities that is consistent with the general, research, implementation, and dissemination activities of the Center for Quality Improvement and Patient Safety, as described in section 933, including— investigator-initiated research to assess diagnostic errors and identify improved methods to prevent errors and the harm they cause; translation and synthesis of research findings and development of tools for implementing prevention strategies into practice; implementation research to refine evidence-based tools for improving diagnostic processes and effectively integrate these solutions into practice; and dissemination to promote implementation of effective methods, strategies and tools for wide-scale improvement. Consistent with section 911(b), such Centers shall link research directly with clinical practice in geographically diverse locations throughout the United States, and may include— academic medical and institutional research centers that combine demonstrated multidisciplinary expertise in diagnostic outcomes or quality improvement research with linkages directly or through national, state or local stakeholder partner organizations to relevant sites of care; provider-based research networks, including plan, facility, or delivery system sites of care (especially primary care), that can evaluate outcomes and evaluate and promote quality improvement approaches. The Director may provide financial assistance to assist in meeting the costs of planning and establishing new centers, as well as operating existing and new centers, pursuant to section 902(c). The Director shall identify and enter into a supporting agreement (grant or contract) with a nonprofit entity that convenes a coalition of diverse health care stakeholders for the purpose of— raising attention to diagnostic safety and quality concerns; facilitating learning, adoption and spread of effective quality improvement interventions; and catalyzing novel actions by individual member organizations to reduce harms from diagnostic error and improve patient outcomes. To carry out this section, there is authorized to be appropriated $20,000,000 for fiscal year 2023, $25,000,000 for fiscal year 2024, $30,000,000 for fiscal year 2025, and $35,000,000 for each of fiscal years 2026 and 2027. Of the amount appropriated under paragraph
(1)for a fiscal year, $700,000 shall be allocated to carrying out the purpose described in subsection (b)(4). Amounts appropriated under this section shall remain available until expended. .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 2
Research program to improve diagnostic safety and quality
Cites 1Cited by 0 across 0 sources